索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]阿布都外力·赛都拉,阿不都拉·阿不都克依木,麦合木提江·穆海麦提糖军伟.骨质疏松药物治疗在脊柱融合术中的影响[J].国际骨科学杂志,2017,06:372-375.
点击复制

骨质疏松药物治疗在脊柱融合术中的影响(PDF)

《国际骨科学杂志》[ISSN:1673-7083/CN:31-1952/R]

期数:
2017年06期
页码:
372-375
栏目:
综述
出版日期:
2017-11-30

文章信息/Info

Title:
-
作者:
阿布都外力·赛都拉; 阿不都拉·阿不都克依木; 麦合木提江·穆海麦提糖军伟
844000, 新疆喀什地区第一人民医院骨科
Author(s):
-
关键词:
骨质疏松药物治疗;  脊柱手术;  脊柱融合
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-7083.2017.06.009
文献标识码:
-
摘要:
脊柱融合术是治疗脊柱退行性疾病的常用手段,临床上需行脊柱融合术的患者常伴有骨质疏松,需要辅助进行骨质疏松治疗,而骨质疏松同时也是影响脊柱融合术并发症的重要因素。目前临床上骨质疏松药物种类繁多,作用机制也不尽相同,主要通过促进钙吸收、抑制破骨细胞活性、促进破骨细胞凋亡、促进成骨细胞活性及激活人体成骨通路等不同作用机制来减少骨质流失及促进骨质形成,从而起到治疗骨质疏松的作用。然而,目前骨质疏松药物对脊柱融合的影响尚未明确,也鲜有文献涉及脊柱融合术围手术期的骨质疏松药物治疗策略。该文就骨质疏松药物对脊柱融合的影响及围手术期药物治疗策略作一综述。
Abstract:
-

参考文献/References

[1] Jagtap VR, Ganu JV, Nagane NS. BMD and serum intact osteocalcin in postmenopausal osteoporosis women[J]. Indian J Clin Biochem, 2011, 26(1):70-73.
[2] Augat P, Schorlemmer S. The role of cortical bone and its microstructure in bone strength[J]. Age Ageing, 2006, 35(Suppl 2):ii27-ii31.
[3] Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis[J]. Lancet, 2007, 370(9588):657-666.
[4] Tai V, Leung W, Grey A, et al. Calcium intake and bone mineral density: systematic review and meta-analysis[J]. BMJ, 2015, 351:h4183.
[5] Metzger MF, Kanim LE, Zhao L, et al. The relationship between serum vitamin D levels and spinal fusion success: a quantitative analysis[J]. Spine(Phila Pa 1976), 2015, 40(8):E458-E468.
[6] Cho JH, Cho DC, Yu SH, et al. Effect of dietary calcium on spinal bone fusion in an ovariectomized rat model[J]. J Korean Neurosurg Soc, 2012, 52(4):281-287.
[7] Bransford R, Goergens E, Briody J, et al. Effect of zoledronic acid in an L6-L7 rabbit spine fusion model[J]. Eur Spine J, 2007, 16(4):557-562.
[8] Sama AA, Khan SN, Myers ER, et al. High-dose alendronate uncouples osteoclast and osteoblast function: a study in a rat spine pseudarthrosis model[J]. Clin Orthop Relat Res, 2004,(425):135-142.
[9] Xue Q, Li H, Zou X, et al. The influence of alendronate treatment and bone graft volume on posterior lateral spine fusion in a porcine model[J]. Spine(Phila Pa 1976), 2005, 30(10):1116-1121.
[10] Takahata M, Ito M, Abe Y, et al. The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model[J]. Bone, 2008, 43(6):1057-1066.
[11] Lehman RA, Kuklo TR, Freedman BA, et al. The effect of alendronate Sodium on spinal fusion: a rabbit model[J]. Spine J, 2004, 4(1):36-43.
[12] Gezici AR, Ergün R, Gürel K, et al. The effect of risedronate on posterior lateral spinal fusion in a rat model[J]. J Korean Neurosurg Soc, 2009, 46(1):45-51.
[13] Babat LB, Mclain R, Milks R, et al. The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model[J]. Spine J, 2005, 5(5):542-547.
[14] Nakao S, Minamide A, Kawakami M, et al. The influence of alendronate on spine fusion in an osteoporotic animal model[J]. Spine(Phila Pa 1976), 2011, 36(18):1446-1452.
[15] Tu CW, Huang KF, Hsu HT, et al. Zoledronic acid infusion for lumbar interbody fusion in osteoporosis[J]. J Surg Res, 2014, 192(1):112-116.
[16] Drake MT, Clarke BL, Lewiecki EM. The pathophysiology and treatment of osteoporosis[J]. Clin Ther, 2015, 37(8):1837-1850.
[17] Andrews EB, Gilsenan AW, Midkiff K, et al. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years[J]. J Bone Miner Res, 2012, 27(12):2429-2437.
[18] Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone(1-34)on fractures and bone mineral density in postmenopausal women with osteoporosis[J]. N Engl J Med, 2001, 344(19):1434-1441.
[19] Lina IA, Puvanesarajah V, Liauw JA, et al. Quantitative study of parathyroid hormone(1-34)and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis[J]. Spine(Phila Pa 1976), 2014, 39(5):347-355.
[20] Ohtori S, Inoue G, Orita S, et al. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study[J]. Spine(Phila Pa 1976), 2012, 37(23):E1464-E1468.
[21] Ohtori S, Inoue G, Orita S, et al. Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective[J]. Spine(Phila Pa 1976), 2013, 38(8):E487-E492.
[22] Ohtori S, Orita S, Yamauchi K, et al. More than 6 months of teriparatide treatment was more effective for bone union than shorter treatment following lumbar posterolateral fusion surgery[J]. Asian Spine J, 2015, 9(4):573-580.
[23] Schulte LM, O’Brien JR, Bean MC, et al. Deep vein thrombosis and pulmonary embolism after spine surgery: incidence and patient risk factors[J]. Am J Orthop(Belle Mead NJ), 2013, 42(6):267-270.
[24] Liu Y, Fan Y, Cao D, et al. Calcitonin enhanced lumbar spinal fusion in a New Zealand rabbit model: a study with morphologic and molecular analysis[J]. Spine(Phila Pa 1976), 2012, 37(3):E139-E146.
[25] Lehman RA, Dmitriev AE, Cardoso MJ, et al. Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model[J]. Spine(Phila Pa 1976), 2010, 35(2):146-152.
[26] Komm BS, Morgenstern D, Yamamoto L, et al. The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women[J]. Expert Rev Clin Pharmacol, 2015, 8(6):769-784.
[27] Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases(SIOMMMS), Italian Society of Rheumatology(SIR), Varenna M, et al. Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature[J]. Reumatismo, 2013, 65(4):143-166.
[28] Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis[J]. N Engl J Med, 2009, 361(8):756-765.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2017-11-30